Budget Amount *help |
¥25,090,000 (Direct Cost: ¥19,300,000、Indirect Cost: ¥5,790,000)
Fiscal Year 2019: ¥6,110,000 (Direct Cost: ¥4,700,000、Indirect Cost: ¥1,410,000)
Fiscal Year 2018: ¥6,110,000 (Direct Cost: ¥4,700,000、Indirect Cost: ¥1,410,000)
Fiscal Year 2017: ¥6,110,000 (Direct Cost: ¥4,700,000、Indirect Cost: ¥1,410,000)
Fiscal Year 2016: ¥6,760,000 (Direct Cost: ¥5,200,000、Indirect Cost: ¥1,560,000)
|
Outline of Final Research Achievements |
We have discovered that the Ca2+ channel, a transmembrane protein that allows Ca2+ to move across the plasma membrane, is the key receptor molecule for influenza virus infections. Furthermore, treating human cells with a calcium channel blocker (CCB), which is commonly used as anti-hypertension drug, significantly suppressed virus infections.
|